TauRx Therapeutics and BrainMind have recently launched new educational materials on the role of tau in Alzheimer’s disease (AD). The illustrations are the result of the peer-reviewed, published science, developed by BrainMind through an educational grant from TauRx, with an aim to explain to doctors and their patients how abnormal tau aggregation affects the brain and how this could be treated. The educational materials are now available online. You can visit https://www.targetingtau.com/ to download these materials. The freely downloadable illustrated guides include a:
-
Educational presentation: It provides in-depth information on the aggregation of tau as Alzheimer’s disease progresses and covers methods of targeting tau to slow the progression of the disease
-
Educational poster: It was developed to provide clinicians with a comprehensive understanding of how pathologic tau aggregation contributes to the progression of Alzheimer’s disease and how it can be stopped.
The content included in this website was created by the nonprofit BrainMind with grant support from TauRx Pharmaceuticals.
